ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,223.13
0.33%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Omeros Corporation (OMER)

  7. Omeros Corporation (OMER) News

Omeros (OMER)

Omeros Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OMER
DateTimeSourceHeadlineSymbolCompany
12/06/202421:48Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
07/06/202422:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
07/06/202422:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
07/06/202422:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
07/06/202422:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
07/06/202422:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
07/06/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
04/06/202414:00Business WireOmeros Announces Webcast Details for Annual Meeting of ShareholdersNASDAQ:OMEROmeros Corporation
03/06/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
03/06/202414:00Business WireOmeros Corporation Further Strengthens its Balance Sheet through Series of Financing Transactions Extending Maturity on a Majority of its Outstanding Debt into 2028NASDAQ:OMEROmeros Corporation
15/05/202421:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMEROmeros Corporation
15/05/202421:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
15/05/202421:02Business WireOmeros Corporation Reports First Quarter 2024 Financial ResultsNASDAQ:OMEROmeros Corporation
10/05/202413:50Business WireOmeros Corporation to Announce First Quarter Financial Results on May 15, 2024NASDAQ:OMEROmeros Corporation
09/05/202413:50Business WireOmeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid CongressNASDAQ:OMEROmeros Corporation
01/04/202421:02Business WireOmeros Corporation Reports Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:OMEROmeros Corporation
27/03/202412:30Business WireOmeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024NASDAQ:OMEROmeros Corporation
20/02/202414:00Business WireOmeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic MicroangiopathyNASDAQ:OMEROmeros Corporation
14/02/202411:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OMEROmeros Corporation
07/02/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
01/02/202414:11Business WireOmeros Corporation Announces Additional Royalty Monetization with DRI Healthcare TrustNASDAQ:OMEROmeros Corporation
29/01/202420:26Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:OMEROmeros Corporation
22/11/202301:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
18/11/202302:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
18/11/202302:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
18/11/202302:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
16/11/202302:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OMEROmeros Corporation
09/11/202321:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OMEROmeros Corporation
09/11/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OMEROmeros Corporation
09/11/202321:02Business WireOmeros Corporation Reports Third Quarter 2023 Financial ResultsNASDAQ:OMEROmeros Corporation
 Showing the most relevant articles for your search:NASDAQ:OMER

Your Recent History

LSE
PANR
Pantheon Resources
LSE
INSG
Insig Ai
LSE
AAZ
Anglo Asian Mining
LSE
ENET
Ethernity Networks
LSE
SDRY
Superdry
LSE
HUM
Hummingbird Resources
LSE
PHNX
Phoenix
LSE
GOLD
LSE
GPM
Golden Prospect Precious...
LSE
AFC
Afc Energy
LSE
SRSP
Sirius Petroleum
LSE
BP.
Bp
LSE
HE1
Helium One Global
LSE
ONDO
Ondo Insurtech
LSE
CNR
Condor Gold
LSE
BATS
British American Tobacco
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved